165 related articles for article (PubMed ID: 2292203)
1. In vitro susceptibility testing of Candida isolates from clinical specimens to four antifungal agents.
Ohkawa M; Tokunaga S; Takashima M; Nishikawa T; Hisazumi H; Fujita S; Wheat RW
Chemotherapy; 1990; 36(6):396-402. PubMed ID: 2292203
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Martín E; Parras P; Lozano MC
Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
Morace G; Manzara S; Dettori G
Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
To WK; Fothergill AW; Rinaldi MG
J Clin Microbiol; 1995 Oct; 33(10):2660-4. PubMed ID: 8567901
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of yeast isolates from the blood to fluconazole and amphotericin B.
Dermoumi H
Chemotherapy; 1992; 38(2):112-7. PubMed ID: 1591946
[TBL] [Abstract][Full Text] [Related]
6. [Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus].
Ohta C; Yamane N; Nakasone I; Onaga S; Nakamura K
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2005; 16(2):127-33. PubMed ID: 16536058
[TBL] [Abstract][Full Text] [Related]
7. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
Fujita S
Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
[TBL] [Abstract][Full Text] [Related]
8. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
9. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
Yang YL; Li SY; Cheng HH; Lo HJ;
Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
Ahearn DG; McGlohn MS
J Clin Microbiol; 1984 Mar; 19(3):412-6. PubMed ID: 6325491
[TBL] [Abstract][Full Text] [Related]
11. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis.
Yang YL; Ho YA; Cheng HH; Ho M; Lo HJ
Infect Control Hosp Epidemiol; 2004 Jan; 25(1):60-4. PubMed ID: 14756222
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
13. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
[TBL] [Abstract][Full Text] [Related]
14. The effect of antifungal drugs in combination on the growth of Candida glabrata in solid and liquid media.
Siau H; Kerridge D
J Antimicrob Chemother; 1998 Mar; 41(3):357-66. PubMed ID: 9578162
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method.
Pfaller MA; Barry AL
Mycopathologia; 1995; 130(1):3-9. PubMed ID: 7666925
[TBL] [Abstract][Full Text] [Related]
16. [Antifungal susceptibility of clinically isolated Candida albicans by broth microdilution method].
Yamazumi T; Kuroda T; Ohata T; Obana Y; Furuta I
Kansenshogaku Zasshi; 1998 Aug; 72(8):813-9. PubMed ID: 9780584
[TBL] [Abstract][Full Text] [Related]
17. A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients.
Still JM; Law EJ; Belcher KE; Spencer SA
Burns; 1995 May; 21(3):167-70. PubMed ID: 7794495
[TBL] [Abstract][Full Text] [Related]
18. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
Matsumoto FE; Dias AL; Melhem MS; Szeszs MW; Auler ME; Ruiz LS; Gonçalves da Silva E; Gandra RF; Paula CR
Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562
[TBL] [Abstract][Full Text] [Related]
19. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
Schmalreck AF; Willinger B; Haase G; Blum G; Lass-Flörl C; Fegeler W; Becker K;
Mycoses; 2012 May; 55(3):e124-37. PubMed ID: 22233267
[TBL] [Abstract][Full Text] [Related]
20. [Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
Yamane N; Igari J
Rinsho Byori; 1997 Feb; 45(2):190-9. PubMed ID: 9121005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
